Trials / Completed
CompletedNCT01423799
Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment
Immunonutrition to Improve Quality of Life of Upper Gastrointestinal Cancer Patients Undergoing Oncological Treatment
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the health-related quality of life following dietary supplementation with an immunonutrition formulation vs an isocaloric/isoprotein control diet supplement in patients suffering from upper digestive tract neoplasia undergoing oncological treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nutritional supplements containing arginine, n-3 and nucleotides | Nutritional intervention with immuno-nutrients |
| DIETARY_SUPPLEMENT | Isocaloric control | Isocaloric and isonitrogenous control without immuno nutrients |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2011-08-26
- Last updated
- 2015-11-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01423799. Inclusion in this directory is not an endorsement.